For patients with stage III or IV high grade serous ovarian carcinomas treated with neoadjuvant chemotherapy with carboplatin – paclitaxel in first line setting (every 3 weeks or weekly), with the intent of a potential interval debulking surgery (disease in place when the chemotherapy is started). This model does not apply to patients treated in recurrent setting.
CA-125 KELIM™ is calculated with at least 3 CA-125 values measured within the first 100 days (or less) after chemotherapy start.
For scientific studies ≥ 2 patients, the website team should be contacted at biomarkers.kinetics@univ-lyon1.fr